Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Will the discovery of more adverse effects of rosiglitazone lead to its suspension in the US?
Read More »Update on Rosiglitazone and its Complications
Prediabetes and Risk for CKD
People with prediabetes and diabetes are at a higher risk of developing chronic kidney disease (CKD) as well as chronic cardiovascular diseases.
Read More »Deadlier Strokes in Patients with Alzheimer’s and Diabetes
Either condition alone may impact stroke risk, and the combination of Alzheimer's and diabetes could be particularly devastating.
Read More »Can ACE Inhibitors Lower Type 2 Diabetes Risk?
ACE inhibitors may have potential uses in diabetes, aside from lowering blood pressure.
Read More »New CV Outcomes Trials Examine Linagliptin and Glimepiride Among Patients With High CVD Risk
The CAROLINA and CARMELINA Trials offer further information regarding the CV safety of linagliptin and glimepiride among patients with T2DM, high CVD risk, and decreased renal function.
Read More »CREDENCE Trial – Overlooked Benefits In Preventing CVD
SGLT2 Inhibitors and their use for preventing cardiovascular diseases.
Read More »How Adipose Tissue Impacts Exercise Tolerance
Can the amount of fat on the heart impact a person’s tolerance for exercise?
Read More »Intensive Glucose Control and Macrovascular Complications
Results from a 15-year observational study.
Read More »Metformin and Cardiovascular Risk
New analysis continues to build the case for metformin and cardiovascular benefits.
Read More »Quality of Dietary Fats And Cardiovascular Mortality
The first prospective analysis to investigate the association between dietary fats and cardiovascular mortality in patients with diabetes.
Read More »